Association of Galectin 9 Expression with Immune Cell Infiltration, Programmed Cell Death Ligand-1 Expression, and Patient’s Clinical Outcome in Triple-Negative Breast Cancer

Galectin-9 (Gal-9) is an immune checkpoint protein that facilitates T cell exhaustion and modulates the tumor-associated microenvironment, and could be a potential target for immune checkpoint inhibition. This study was conducted to assess Gal-9 expression in triple-negative breast cancer (TNBC) and...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Mi-Ha Ju, Kyung-Do Byun, Eun-Hwa Park, Jin-Hwa Lee, Song-Hee Han
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Subjects:	Galectin-9 triple-negative breast cancer tumor-infiltrating lymphocyte PD-L1
Online Access:	https://www.mdpi.com/2227-9059/9/10/1383

Similar Items

The significance of programed cell death‐ligand 1 expression in vestibular schwannoma
by: Se A Lee, et al.
Published: (2023-09-01)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
by: Byung-Hyun Lee, et al.
Published: (2021-06-01)

Galectin-9 – ligand axis: an emerging therapeutic target for multiple myeloma
by: Rajib K. Shil, et al.
Published: (2024-09-01)

Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
by: Xierenguli Alimu, et al.
Published: (2023-05-01)

The role of galectins in mediating the adhesion of circulating cells to vascular endothelium
by: Joseph Souchak, et al.
Published: (2024-05-01)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01)

Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
by: Yuanwei Shi, et al.
Published: (2022-05-01)

Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function
by: Annat Raiter, et al.
Published: (2025-02-01)

The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
by: Zerrin Barut, et al.
Published: (2023-09-01)

THE ROLE OF TUMOR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER
by: Anca Zgura, et al.
Published: (2018-09-01)

Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)

Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration
by: Xiuwen Chen, et al.
Published: (2024-08-01)

The content of soluble forms of galectins -1, -3, -4, -7, -9 in patients with renal cell cancer of various morphological types
by: Nikolay E. Kushlinskii, et al.
Published: (2024-09-01)

The regulating role of galectin-9 in immune cell populations
by: Zhanqi Cao, et al.
Published: (2024-10-01)

Diffuse large B-cell lymphoma: the significance of CD8+ tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway
by: Qiqi Zhu, et al.
Published: (2024-02-01)

The role of galectin-1 in the T-lymphocytes homeostasis
by: V. D. Yakushina, et al.
Published: (2011-12-01)

Galectin-9 as a Potential Modulator of Lymphocyte Adhesion to Endothelium via Binding to Blood Group H Glycan
by: Eugenia M. Rapoport, et al.
Published: (2023-07-01)

Unveiling the Landscape of PD-L1 Expression and Tumor-Infiltrating Lymphocyte Subtypes in Advanced Triple-Negative Breast Cancer in Brazil
by: Dos Santos ALS, et al.
Published: (2025-04-01)

PD-L1 Expression in Different Segments and Histological Types of Ovarian Cancer According to Lymphocytic Infiltrate
by: Ljubiša Jovanović, et al.
Published: (2021-11-01)

Serum Galectin‐1, Galectin‐9, and YKL‐40 levels in bipolar disorder and their relationship with cognitive functions
by: Elcicek Selahaddin, et al.
Published: (2024-02-01)

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
by: Silvio Däster, et al.
Published: (2020-04-01)

Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01)

Expression of galectin-9 mRNA in obese children with polymorphism of the lactase gene
by: A.E. Abaturov, et al.
Published: (2018-02-01)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01)

Galectin-3 Marker Expression in Renal Cell Carcinoma and Correlation with patient Clinicopathologic Factors: A cross-sectional study
by: Ghodsieh Kamrani, et al.
Published: (2025-10-01)

Endometrial regenerative cells with galectin-9 high-expression attenuate experimental autoimmune hepatitis
by: Hongda Wang, et al.
Published: (2021-10-01)

The role of galectin-1 and galectin-3 in the mechanisms of T-cell immune response dysregulation in colon cancer
by: V. S. Poletika, et al.
Published: (2020-10-01)

Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study
by: Parisa Lotfinejad, et al.
Published: (2020-09-01)

Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression
by: Ravi Chauhan, et al.
Published: (2024-07-01)

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer
by: A. F. Nasretdinov, et al.
Published: (2020-06-01)

Prognosis-related novel immunostaining pattern for programmed cell death ligand 1 and prognostic value of tumour-infiltrating lymphocytes in triple-negative breast cancer
by: Pınar Savaş, et al.
Published: (2023-06-01)

The Prevalence of PD-L1 Expression in Triple-Negative Breast Cancer Patients and Its Correlation with Survival Rates and Other Prognostic Factors: A Survival Analysis
by: Arefeh Izadi, et al.
Published: (2024-09-01)

Expression of Programmed Death Ligand-1 and Correlation with Clinicopathological Features and CD8 Infiltration in Breast Cancer
by: Shahenaz S Salih, et al.
Published: (2023-06-01)

Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer
by: Özgecan Dülgar, et al.
Published: (2020-10-01)

Galectin-9 Expression Profile in Patients with Gastric Cancer and Peptic Ulcer Disease
by: Mahdieh Naghavi-Alhosseini, et al.
Published: (2016-11-01)

Galectin-9 expression on tumor-associated immune cells is associated with favorable clinicopathological features and better outcomes in oral squamous cell carcinoma
by: Rafał Pęksa, et al.
Published: (2023-04-01)

Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer
by: Eunkyung Han, et al.
Published: (2024-12-01)

Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
by: Minpu Zhang, et al.
Published: (2024-01-01)

PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
by: Ki Hyung Kim, et al.
Published: (2019-06-01)

Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade
by: Charlotte N. Hill, et al.
Published: (2025-07-01)